425: Strive CRO Reposts Merger Update with Semler Scientific

Strive, Inc.'s Chief Risk Officer reposted a communication on X.com regarding the proposed business combination with Semler Scientific, Inc., emphasizing forward-looking statements and associated risks.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc.
• The communication was originally reposted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on January 8, 2026.
• The filing primarily serves as a cautionary statement regarding forward-looking statements related to the proposed transaction.
• It highlights various risks and uncertainties that could cause actual results to differ materially from anticipated outcomes.
• The document directs investors to other SEC filings, including Registration Statement on Form S-4, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, for additional detailed information.

Sentiment

Score: 5

Explanation: The filing is a procedural communication regarding a proposed merger, primarily focusing on cautionary statements and risks, without presenting new financial results or operational updates. Its tone is neutral and informative about the merger process.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all due to conditions not being met or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

Forward-looking statements indicate expectations regarding the strategic and financial benefits of the proposed transaction, including its expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. However, these statements are subject to significant risks and uncertainties.

Management Comments

• Jeff Walton, Chief Risk Officer of Strive, Inc., reposted the communication on X.com on January 8, 2026, concerning the proposed business combination with Semler Scientific, Inc.

Industry Context

This communication is a standard procedural filing related to a proposed merger, providing cautionary statements rather than specific industry analysis. The mention of Bitcoin treasury strategies suggests Strive's involvement or planned involvement in digital asset management, which is a growing trend in corporate finance for some companies.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the transaction.
• Customers of both Strive and Semler Scientific may have adverse reactions or changes to business relationships.
• Employee relationships at both companies could be affected by the announcement or completion of the proposed transaction.

Next Steps

• Semler Scientific stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus to make voting or investment decisions.
• Approval of the proposed transaction by Semler Scientific stockholders.
• Closing of the proposed transaction.
• Successful integration of the combined businesses.

Key Dates

Recommendation

This filing is a procedural communication regarding a proposed business combination, primarily outlining forward-looking statements and associated risks. Without new financial results or definitive merger terms, a 'hold' recommendation is appropriate to await further developments and the successful completion of the transaction. Investors should review the referenced S-4 and other filings for comprehensive financial and operational details.

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, forward-looking statements, Bitcoin treasury, corporate governance, risk management